[Sensitivity to beta lactams and macrolides of Streptococcus pyogenes isolated at the services from 1994 to 1998].
The identification and antibiotic sensibility of 188 strains of streptocoques pyogenes had been performed from 1994 to March 1998. We were interested on active antibiotics against streptocoques pyogenes: beta lactamins (penicillin-ampicillin) and macrolids (erythromycin). The aim of this study is to reveal resistances and calculate percentages of resistant strains to these antibiotics. The WHO recommend to treat streptococcal sore throat with penicillin, and with erythromycin when there is a proved inhibility to the penicillin. No penicillin resistant streptocoques pyogenes has been found in the world, that concords with our study: all strains (188 sp.) are penicillin sensitive. Macrolids resistant strains of streptocoques pyogenes has been described by a lot of countries with different distributions. In our study global percentage of resistant strains to erythromycin is 24% and 29% for throat specimen.
Service de Bactériologie Médicale, d'Antibiothérapie et d'Hygiène Hospitalière: Institut Pasteur d'Algérie.
S
S
Nait-Kaci
W
W
Boukarana
K
K
Rahal
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004917:Erythromycin / Q000494:pharmacology*; D006801:Humans; D018942:Macrolides / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D010406:Penicillins / Q000494:pharmacology*; D013297:Streptococcus pyogenes / Q000187:drug effects* / Q000302:isolation & purification; D047090:beta-Lactams / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D018942:Macrolides; D010406:Penicillins; D047090:beta-Lactams; D004917:Erythromycin